Cargando…

Dipyridamole Combined with Tumor Necrosis Factor‐α Enhances Inhibition of Proliferation in Human Tumor Cell Lines

In the search for cytokines whose antiproliferative action could be enhanced by combination with dipyridamole, 2,6‐bis(diethanolamino)‐4,8‐dipiperidinopyrimido[5,4,d]pyrimidine, the combination of tumor necrosis factor‐α (TNF‐α) with this agent was evaluated in various human tumor cell lines. Inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Nobuo, Sekiya, Souei, Sugano, Isamu, Kojima, Takayuki, Yamamori, Hideo, Takakubo, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1995
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920906/ https://www.ncbi.nlm.nih.gov/pubmed/7559100 http://dx.doi.org/10.1111/j.1349-7006.1995.tb02466.x

Ejemplares similares

Establishment and Characterization of a Human Cell Strain, KT, with High Sensitivity to UV‐killing and to Cell Proliferation Inhibition by Interferon
por: Suzuki, Nobuo, et al.
Publicado: (1988)

Dipyridamole induces the phosphorylation of CREB to promote cancer cell proliferation
por: Abdelghany, Lina, et al.
Publicado: (2021)

Characterization of a 54 kDa, α(1)Antitrypsin‐like Protein Isolated from Ascitic Fluid of an Endometrial Cancer Patient
por: Tanaka, Naotake, et al.
Publicado: (1991)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines.
por: Hirose, M., et al.
Publicado: (1987)

Dipyridamole and vascular healing following stent implantation
por: Simard, Trevor, et al.
Publicado: (2023)

In vivo Anti‐tumor Efficacy of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α against Tumor Necrosis Factor‐resistant Tumors
por: Tsutsumi, Yasuo, et al.
Publicado: (1996)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α
por: Corti, Angelo, et al.
Publicado: (2022)

Dipyridamole augments the antiinflammatory response during human endotoxemia
por: Ramakers, Bart P, et al.
Publicado: (2011)

The signal pathway for the repressive effect of dipyridamole on myofibroblast transdifferentiation
por: Yan, Qiong, et al.
Publicado: (2018)

Dipyridamole-induced STEMI: case report and review of the literature
por: Hennawi, Hussam Al, et al.
Publicado: (2023)

Potentiation of Some Anticancer Agents by Dipyridamole against Drug‐sensitive and Drug‐resistant Cancer Cell Lines
por: Asoh, Kuni‐ichi, et al.
Publicado: (1989)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

Salivary tumor necrosis factor-α and periodontal destruction
por: Tin, Sim Sai, et al.
Publicado: (2015)

Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
por: Salomon, Benoît L., et al.
Publicado: (2018)

Tumor necrosis factor α Inhibition for Alzheimer’s Disease
por: Chang, Rudy, et al.
Publicado: (2017)

Tumor Necrosis Factor-α: The Next Marker of Stroke
por: Xue, Yimeng, et al.
Publicado: (2022)

Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
por: Kitaura, Hideki, et al.
Publicado: (2022)

MicroRNA-21 regulates the proliferation and apoptosis of cervical cancer cells via tumor necrosis factor-α
por: Xu, Lin, et al.
Publicado: (2017)

Dipyridamole modulates the innate immune response during human endotoxemia
por: Ramakers, B, et al.
Publicado: (2011)

Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration
por: Rogosnitzky, Moshe, et al.
Publicado: (2016)

The possible protective effects of dipyridamole on ischemic reperfusion injury of priapism
por: Karaguzel, Ersagun, et al.
Publicado: (2016)

Assessment of dipyridamole stress echocardiography for risk stratification of diabetic patients
por: Baroncini, Liz Andréa Villela, et al.
Publicado: (2015)

Reduction of microglial activity in a model of multiple sclerosis by dipyridamole
por: Sloka, Scott, et al.
Publicado: (2013)

Unusual Dipyridamole-induced Aberrant Conduction in the Absence of Myocardial Ischemia
por: Ricca-Mallada, Roberto, et al.
Publicado: (2017)

Atrioventricular (AV) block and sinus arrest associated with dipyridamole infusion
por: Khalili, Mahdi, et al.
Publicado: (2022)

Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced α(1)-acid glycoprotein binding
por: Curtin, N J, et al.
Publicado: (1999)

The Possible Role of Tumor Necrosis Factor-α in Diabetic Polyneuropathy
por: Satoh, Jo, et al.
Publicado: (2003)

Nontuberculous Mycobacterium Infection and Tumor Necrosis Factor-α Antagonists
por: Swart, Reinout M., et al.
Publicado: (2009)

Therapeutic targeting of tumor hypoxia and necrosis with antibody α-radioconjugates
por: Staudacher, Alexander H, et al.
Publicado: (2018)

Augmentation by Tumor Necrosis Factor α of the Systemic Therapeutic Effect of Lymphokine‐activated Killer Cells in Adoptive Immunotherapy of Murine Tumor
por: Kato, Kazunori, et al.
Publicado: (1991)

Co‐production of Interleukin‐1 and Interleukin‐6 in Tumor Cell Lines Elaborating Colony‐stimulating Factors
por: Okuno, Yoshiaki, et al.
Publicado: (1991)

Tumor Necrosis Factor α from Peripheral Blood Mononuclear Cells of IgA Nephropathy and Mesangial Cell Proliferation
por: Lee, Tae-Won, et al.
Publicado: (1994)

Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis
Publicado: (1993)

Efficacy of Anti-Tumor Necrosis Factor-α Therapy Against Intestinal Behçet’s Disease Complicated by Recurrent Enterocutaneous Fistulae
por: Kashima, Hitomi, et al.
Publicado: (2022)

Bacteriologically Determined De Novo Tuberculosis during Tumor Necrosis Factor-α Inhibitor Therapy
por: Takahashi, Gen, et al.
Publicado: (2019)

Tumor necrosis factor α-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis
por: Inoue, Asuka, et al.
Publicado: (2009)

Multiple roles for tumor necrosis factor-α and lymphotoxin α/β in immunity and autoimmunity
por: McDevitt, Hugh, et al.
Publicado: (2002)

Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_dkqlj80rd3c8cqi42jvdir4kcq